Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.55%626.58M | 13.91%614.72M | 12.35%2.27B | 9.18%563.19M | 10.10%561.38M | 14.58%605.08M | 15.78%539.65M | 5.19%2.02B | 10.13%515.85M | 2.63%509.86M |
| Net interest income | 0.40%365.74M | 6.84%369.75M | 10.81%1.45B | 8.32%371.36M | 10.67%369.39M | 11.09%364.3M | 13.46%346.08M | 6.46%1.31B | 13.25%342.85M | 1.83%333.79M |
| -Total interest income | 2.81%735.53M | 9.79%746.89M | 16.19%2.87B | 12.74%738.88M | 15.77%730.55M | 17.06%715.46M | 19.71%680.26M | 24.80%2.47B | 22.92%655.38M | 19.89%631.01M |
| -Total interest expense | 5.31%369.79M | 12.86%377.15M | 22.29%1.41B | 17.59%367.52M | 21.51%361.15M | 23.97%351.16M | 26.94%334.19M | 55.06%1.16B | 35.63%312.53M | 49.70%297.22M |
| Non interest income | 8.33%260.84M | 26.56%244.97M | 15.19%818.16M | 10.88%191.82M | 9.04%191.98M | 20.29%240.79M | 20.16%193.57M | 2.93%710.3M | 4.43%173.01M | 4.19%176.07M |
| -Fees and commissions | 94.77%35.48M | 1.59%33.35M | -23.08%113.3M | 5.07%30.91M | -23.46%31.34M | -56.96%18.22M | -5.14%32.83M | 32.89%147.3M | 14.65%29.41M | 40.69%40.94M |
| -Including:Fees and commission income | -5.04%70.71M | -0.88%66.23M | -2.13%270.84M | -16.36%62.17M | -7.30%67.39M | 6.08%74.46M | 12.25%66.82M | 28.22%276.74M | 41.95%74.32M | 36.79%72.7M |
| -Including:Fees and commission expense | -37.37%35.22M | -3.26%32.88M | 21.70%157.54M | -30.39%31.26M | 13.54%36.05M | 101.83%56.24M | 36.39%33.99M | 23.30%129.45M | 68.18%44.91M | 32.07%31.75M |
| -Dividend income | 646.79%2.09M | 4.46%1.13M | 0.07%1.36M | --0 | --0 | 0.72%280K | -0.09%1.08M | -41.07%1.36M | --0 | --0 |
| -Gain loss on sale of securities | -26.07%185.19M | 11.20%141.72M | 32.55%583.86M | 38.93%168.27M | 127.68%200.71M | 111.32%250.5M | 13.09%127.44M | -4.44%440.5M | 48.46%121.12M | 172.62%88.15M |
| -Net reversal of impairment loss of financial instruments | -161.38%-348K | 97.67%255K | 6.96%615K | -93.02%22K | -271.67%-103K | 2,735.00%567K | -14.00%129K | 225.00%575K | 262.07%315K | 126.67%60K |
| -Total other operating income | 613.56%8.98M | -275.40%-15.83M | 578.59%90.59M | -126.33%-11.39M | 270.14%107.95M | -118.14%-1.75M | 49.80%-4.22M | -153.21%-18.93M | 208.21%43.28M | -118.73%-63.44M |
| Credit losses provision | -41.28%55.17M | 98.74%88.86M | 37.77%183.06M | -83.10%7.97M | 55.61%38.38M | 244.68%93.95M | 27.24%44.71M | -10.26%132.87M | -13.05%47.16M | -33.01%24.66M |
| Operating expense | 9.18%298.67M | 7.06%277.61M | 11.79%1.09B | 16.58%290.49M | 7.03%265.15M | 10.87%273.56M | 12.70%259.29M | 10.48%973.73M | 3.40%249.18M | 11.73%247.73M |
| Staff costs | 1.76%185.41M | 6.55%179.4M | 8.68%684.5M | 10.20%176.57M | -0.63%157.34M | 13.46%182.2M | 11.75%168.38M | 9.99%629.82M | 6.91%160.23M | 8.50%158.33M |
| Selling and administrative expenses | 24.85%35.72M | -4.74%27.58M | 17.37%133.45M | 47.74%40.3M | 12.69%35.59M | -4.95%28.61M | 17.00%28.95M | 27.14%113.7M | -13.99%27.28M | 44.93%31.58M |
| -Selling and marketing expense | 19.17%15.38M | -10.83%11.78M | 31.89%62.08M | 76.67%19.36M | 21.17%16.61M | 18.71%12.91M | 14.49%13.21M | 58.33%47.07M | -8.37%10.96M | 190.11%13.71M |
| -General and administrative expense | 29.52%20.34M | 0.37%15.8M | 7.11%71.37M | 28.30%20.94M | 6.19%18.98M | -18.33%15.71M | 19.20%15.74M | 11.61%66.63M | -17.39%16.32M | 4.74%17.87M |
| Depreciation and amortization | 29.69%32.43M | 4.91%26.47M | 3.41%101.01M | 1.43%25.6M | 4.10%25.18M | 4.49%25.01M | 3.72%25.23M | 3.96%97.67M | 5.16%25.24M | 2.32%24.18M |
| -Depreciation | 39.68%18.37M | 11.08%14.61M | 7.80%53.95M | 5.97%14.03M | 8.81%13.61M | 8.65%13.15M | 7.91%13.15M | 8.68%50.05M | 14.67%13.24M | 8.27%12.51M |
| -Amortization | 18.60%14.06M | -1.82%11.85M | -1.20%47.06M | -3.58%11.57M | -0.94%11.56M | 0.24%11.85M | -0.49%12.07M | -0.57%47.63M | -3.65%12M | -3.38%11.67M |
| Rent and land expenses | 319.64%235K | -59.80%160K | -46.47%660K | -31.70%153K | -77.06%53K | -82.87%56K | -11.75%398K | -35.17%1.23M | -46.67%224K | -54.26%231K |
| Insurance and claims | 22.30%4.06M | 43.67%4.17M | -8.59%13.25M | 0.19%3.72M | -6.23%3.3M | -9.13%3.32M | -19.39%2.9M | 2.91%14.49M | 7.62%3.72M | 1.06%3.52M |
| Other operating expenses | 18.75%40.81M | 19.13%39.83M | 33.24%155.65M | 35.86%44.15M | 46.19%43.7M | 22.14%34.36M | 27.15%33.44M | 6.79%116.82M | 3.08%32.49M | 13.28%29.89M |
| Income from associates and other participating interests | -41.67%7K | 8.33%13K | 14.63%47K | -26.67%11K | 200.00%12K | 33.33%12K | -7.69%12K | -10.87%41K | 36.36%15K | -55.56%4K |
| Special income (charges) | -5,197.06%-1.8M | 51.99%-531K | -143.45%-4.85M | -115.57%-1.76M | 99.73%-34K | -349.10%-1.11M | 52.50%-1.99M | 372.18%11.32M | ||
| Less:Other special charges | ---- | ---345K | ---34K | ---34K | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | 5,197.06%1.8M | -20.80%876K | 145.16%4.89M | 115.87%1.8M | ---- | -99.73%34K | 349.10%1.11M | -53.39%1.99M | ---11.32M | ---- |
| Income before tax | 14.06%270.95M | 5.62%247.73M | 8.95%992.93M | 13.92%262.97M | 8.59%257.86M | -1.70%237.55M | 16.49%234.55M | 2.79%911.32M | 36.56%230.84M | -0.33%237.47M |
| Income tax | 35.15%64.39M | -15.30%49.03M | 9.67%242.2M | 23.31%65.48M | 17.46%71.19M | -15.44%47.64M | 13.95%57.89M | 5.79%220.85M | 36.61%53.1M | -0.88%60.61M |
| Net income | 8.77%206.56M | 12.48%198.7M | 8.73%750.73M | 11.11%197.49M | 5.55%186.67M | 2.47%189.91M | 17.34%176.65M | 1.86%690.48M | 36.55%177.74M | -0.13%176.86M |
| Net income continuous operations | 8.77%206.56M | 12.48%198.7M | 8.73%750.73M | 11.11%197.49M | 5.55%186.67M | 2.47%189.91M | 17.34%176.65M | 1.86%690.48M | 36.55%177.74M | -0.13%176.86M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 8.77%206.56M | 12.48%198.7M | 8.73%750.73M | 11.11%197.49M | 5.55%186.67M | 2.47%189.91M | 17.34%176.65M | 1.86%690.48M | 36.55%177.74M | -0.13%176.86M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 8.77%206.56M | 12.48%198.7M | 8.73%750.73M | 11.11%197.49M | 5.55%186.67M | 2.47%189.91M | 17.34%176.65M | 1.86%690.48M | 36.55%177.74M | -0.13%176.86M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 0.96%0.121 | 15.23%0.128 | 8.74%0.4726 | 11.30%0.1247 | 6.14%0.1179 | 2.50%0.1199 | 17.53%0.1111 | 1.83%0.4346 | 36.90%0.1121 | 0.00%0.1111 |
| Diluted earnings per share | 0.96%0.121 | 15.23%0.128 | 8.74%0.4726 | 11.30%0.1247 | 6.14%0.1179 | 2.50%0.1199 | 17.53%0.1111 | 1.83%0.4346 | 36.90%0.1121 | 0.00%0.1111 |
| Dividend per share | 0 | -13.54%0.0965 | 0.48%0.2041 | 0 | -12.44%0.0926 | 0 | 14.50%0.1116 | -6.08%0.2032 | 0 | -9.58%0.1057 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.